1
- --------------------------------------------------------------------------------
FORM 8-K
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
20549
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(B) OF THE SECURITIES
EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED) APRIL 20, 2000
COMMISSION FILE NUMBER 1-10629
LASER VISION CENTERS, INC.
(Exact name of registrant as specified in its charter)
Delaware 43-1530063
---------------------------------- -----------------------------
(State or other jurisdiction of incorporation (I.R.S. Employer
or organization) Identification Number)
540 Maryville Centre Drive, Suite 200, St. Louis, Missouri 63141
(Address of principal executive offices)
(314) 434-6900
(Registrant's telephone number, including area code)
- --------------------------------------------------------------------------------
2
FORM 8-K
ITEM 5. OTHER EVENTS
On April 20, 2000, the Company issued a press release pertaining to the Company
being served with an administrative complaint issued by the Center For Devices
and Radiological Health of the United States Food and Drug Administration (FDA).
A copy of that press release is attached hereto as an exhibit.
ITEM 7(C): LIST OF EXHIBITS FILED
99.1 Press Release dated April 20, 2000.
-2-
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
LASER VISION CENTERS, INC.
BY: /S/ JOHN J. KLOBNAK
-------------------------------
JOHN J. KLOBNAK
Chief Executive Officer
Date: April 21, 2000
- --------------------------------------------------------------------------------
-3-